Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[A case report of intrahepatic cholangiocarcinoma diagnosed as lung cancer with liver metastasis treated with radiofrequency ablation].
Fukushima K, Kido M, Fukumoto T, Hori Y, Kusunoki N, Tsuchida S, Takahashi M, Tanaka M, Kuramitsu K, Tsugawa D, Gon H, Chuma M, Urade T, Matsumoto I, Ajiki T, Ku Y, Kanzawa M, Ito T. Fukushima K, et al. Among authors: chuma m. Gan To Kagaku Ryoho. 2011 Nov;38(12):2030-2. Gan To Kagaku Ryoho. 2011. PMID: 22202274 Japanese.
[A case report of multiple advanced hepatocellular carcinomas treated by combination therapy with hepatectomy and particle therapy].
Urade T, Kido M, Fukumoto T, Hori Y, Kusunoki N, Tsuchida S, Takahashi M, Tanaka M, Kuramitsu K, Tsugawa D, Gon H, Chuma M, Fukushima K, Matsumoto I, Ajiki T, Terashima K, Demizu Y, Murakami M, Ku Y. Urade T, et al. Among authors: chuma m. Gan To Kagaku Ryoho. 2011 Nov;38(12):2065-7. Gan To Kagaku Ryoho. 2011. PMID: 22202285 Japanese.
[A case of bilobar multiple hepatocellular carcinoma in which complete remission was achieved by preoperative percutaneous isolated hepatic perfusion and subsequent hepatectomy].
Urade T, Tanaka M, Fukumoto T, Kido M, Tsuchida S, Takahashi M, Takebe A, Kuramitsu K, Awazu M, Chuma M, Fukushima K, So S, Tai K, Fujimoto M, Toyama H, Shinzeki M, Matsumoto I, Ajiki T, Ku Y. Urade T, et al. Among authors: chuma m. Gan To Kagaku Ryoho. 2012 Nov;39(12):1825-7. Gan To Kagaku Ryoho. 2012. PMID: 23267899 Japanese.
Unveiling the association between fluoroquinolones and aortic diseases using real-world database analysis and pharmacological experiments.
Miyata K, Izawa-Ishizawa Y, Tsujinaka K, Nishi H, Itokazu S, Miyata T, Kondo M, Yoshioka T, Niimura T, Aizawa F, Yagi K, Sato M, Hyodo M, Hamano H, Kawada K, Chuma M, Zamami Y, Tsuneyama K, Goda M, Ishizawa K. Miyata K, et al. Among authors: chuma m. Biomed Pharmacother. 2024 Oct;179:117418. doi: 10.1016/j.biopha.2024.117418. Epub 2024 Sep 11. Biomed Pharmacother. 2024. PMID: 39265233 Free article.
Real-world Effectiveness and Tolerability of Interferon-free Direct-acting Antiviral for 15,849 Patients with Chronic Hepatitis C: A Multinational Cohort Study.
Ji F, Tran S, Ogawa E, Huang CF, Suzuki T, Wong YJ, Toyoda H, Jun DW, Li L, Uojima H, Nozaki A, Chuma M, Tseng CH, Hsu YC, Ishigami M, Honda T, Atsukawa M, Haga H, Enomoto M, Trinh H, Preda CM, Vutien P, Landis C, Lee DH, Watanabe T, Takahashi H, Abe H, Asai A, Eguchi Y, Li J, Wang X, Li J, Liu J, Liang J, Lam CP, Huang R, Ye Q, Pan H, Zhang J, Cai D, Wang Q, Huang DQ, Wong G, Wong VW, Li J, Do S, Furusyo N, Nakamuta M, Nomura H, Kajiwara E, Yoon EL, Ahn SB, Azuma K, Dohmen K, An J, Song DS, Cho HC, Kawano A, Koyanagi T, Ooho A, Satoh T, Takahashi K, Yeh ML, Tsai PC, Yasuda S, Zhao Y, Liu Y, Okubo T, Itokawa N, Jun MJ, Ishikawa T, Takaguchi K, Senoh T, Zhang M, Zhao C, Alecu RI, Xuan Tay W, Devan P, Liu JK, Kozuka R, Vargas-Accarino E, Do AT, Maeda M, Chuang WL, Huang JF, Dai CY, Cheung R, Buti M, Niu J, Xie W, Ren H, Lim SG, Wu C, Yuen MF, Shang J, Zhu Q, Ueno Y, Tanaka Y, Hayashi J, Yu ML, Nguyen MH. Ji F, et al. Among authors: chuma m. J Clin Transl Hepatol. 2024 Jul 28;12(7):646-658. doi: 10.14218/JCTH.2024.00089. Epub 2024 Jun 17. J Clin Transl Hepatol. 2024. PMID: 38993510 Free PMC article.
Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinoma.
Chuma M, Uojima H, Toyoda H, Hiraoka A, Arase Y, Atsukawa M, Itokawa N, Okubo T, Tada T, Numata K, Morimoto M, Sugimori M, Nozaki A, Iwasaki S, Yasuda S, Koshiyama Y, Mishima Y, Tsuruya K, Tokoro C, Miura Y, Hidaka H, Kumada T, Kusano C, Kagawa T, Maeda S. Chuma M, et al. Hepatol Int. 2024 Oct;18(5):1472-1485. doi: 10.1007/s12072-024-10680-8. Epub 2024 Jul 4. Hepatol Int. 2024. PMID: 38963640
Lenvatinib radiofrequency ablation sequential therapy offers survival benefits for patients with unresectable hepatocellular carcinoma at intermediate stage and the liver reserve of Child-Pugh A category: A multicenter study.
Zhang Y, Numata K, Imajo K, Uojima H, Funaoka A, Komiyama S, Ogushi K, Chuma M, Irie K, Kokubu S, Yoneda M, Kobayashi T, Hidaka H, Fukushima T, Kobayashi S, Morimoto M, Kagawa T, Hattori N, Watanabe T, Iwase S, Maeda S. Zhang Y, et al. Among authors: chuma m. Hepatol Res. 2024 Jul 2. doi: 10.1111/hepr.14089. Online ahead of print. Hepatol Res. 2024. PMID: 38953838
174 results